• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超重是侵蚀性和非侵蚀性反流病的一个风险因素。

Overweight is a risk factor for both erosive and non-erosive reflux disease.

机构信息

Division of Gastroenterology, Department of Internal Medicine, University of Genoa, Genoa, Italy.

出版信息

Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22.

DOI:10.1016/j.dld.2011.07.014
PMID:21944835
Abstract

INTRODUCTION

Studies have reported that the association between overweight and erosive oesophagitis is very strong, whilst seeming less consistent with non-erosive reflux disease.

AIM

We have hypothesized that this difference may be due to the heterogeneity of endoscopy-negative population.

METHODS

We studied 81 patients with erosive oesophagitis, 48 controls and 295 endoscopy-negative patients classified by impedance-pH-testing as: (1) pH-POS (abnormal acid exposure); (2) hypersensitive oesophagus (normal acid exposure/SAP+); (3) functional heartburn (normal acid exposure/SAP-). Body mass index was also calculated.

RESULTS

Mean body mass index was significantly higher (p<0.05) in erosive oesophagitis than in endoscopy-negative patients as a whole and controls [27 (18-40) vs. 25 (16-48) vs. 23 (16-34)]. However, the separation of endoscopy-negative patients showed that mean body mass index was higher (p<0.05) in those with increased acid exposure time [26 (18-45)] than in hypersensitive oesophagus [24 (16-48)]. The former subgroup was similar to erosive oesophagitis, whilst the latter one to both functional heartburn [23 (16-34)] and controls (p=ns). Increased body mass index represented a risk factor for erosive oesophagitis (odds ratio 1.4; 95% confidence interval, 1.2-1.6) and non-erosive reflux disease pH-POS subgroup (odds ratio 1.35; 95% confidence interval, 1.2-1.5).

CONCLUSION

Our study shows that overweight represents an important risk factor for erosive oesophagitis and pH-POS non-erosive reflux disease and not for hypersensitive oesophagus and functional heartburn. This provides an explanation for the previously reported lesser role of this variable in non-erosive reflux disease population.

摘要

简介

研究表明,超重与侵蚀性食管炎之间的关联非常强,而与非侵蚀性反流病的关联似乎不太一致。

目的

我们假设这种差异可能是由于内镜阴性人群的异质性所致。

方法

我们研究了 81 例侵蚀性食管炎患者、48 例对照者和 295 例内镜阴性患者,这些患者通过阻抗-pH 检测分为以下几类:(1)pH-POS(异常酸暴露);(2)高敏感食管(正常酸暴露/SAP+);(3)功能性烧心(正常酸暴露/SAP-)。同时还计算了体重指数。

结果

与内镜阴性患者总体和对照组相比,侵蚀性食管炎患者的平均体重指数显著更高(p<0.05)[27(18-40)比 25(16-48)比 23(16-34)]。然而,内镜阴性患者的分组显示,酸暴露时间增加的患者的平均体重指数更高(p<0.05)[26(18-45)],高于高敏感食管患者[24(16-48)]。前者亚组与侵蚀性食管炎相似,而后者与功能性烧心[23(16-34)]和对照组相似(p=ns)。较高的体重指数是侵蚀性食管炎(比值比 1.4;95%置信区间,1.2-1.6)和非侵蚀性反流病 pH-POS 亚组(比值比 1.35;95%置信区间,1.2-1.5)的危险因素。

结论

我们的研究表明,超重是侵蚀性食管炎和 pH-POS 非侵蚀性反流病的重要危险因素,但不是高敏感食管和功能性烧心的危险因素。这解释了之前报道的在非侵蚀性反流病人群中该变量作用较小的原因。

相似文献

1
Overweight is a risk factor for both erosive and non-erosive reflux disease.超重是侵蚀性和非侵蚀性反流病的一个风险因素。
Dig Liver Dis. 2011 Dec;43(12):940-5. doi: 10.1016/j.dld.2011.07.014. Epub 2011 Sep 22.
2
The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.阻抗-pH 监测对罗马 III 标准在区分功能性烧心和非糜烂性反流病中的附加价值。
Dig Liver Dis. 2011 Jul;43(7):542-7. doi: 10.1016/j.dld.2011.01.016. Epub 2011 Mar 3.
3
The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.不同胃食管反流病组之间食管酸暴露重叠的程度。
Aliment Pharmacol Ther. 2006 Jan 15;23(2):321-9. doi: 10.1111/j.1365-2036.2006.02747.x.
4
Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?各种形式的胃食管反流病的病理生理特征。是谱系疾病还是不同的表型表现?
Dig Liver Dis. 2006 Sep;38(9):643-8. doi: 10.1016/j.dld.2006.02.020. Epub 2006 Apr 14.
5
The added value of quantitative analysis of on-therapy impedance-pH parameters in distinguishing refractory non-erosive reflux disease from functional heartburn.治疗中阻抗-pH 参数定量分析在鉴别难治性非糜烂性反流病与功能性烧心中的附加价值。
Neurogastroenterol Motil. 2012 Feb;24(2):141-6, e87. doi: 10.1111/j.1365-2982.2011.01800.x. Epub 2011 Oct 12.
6
Characteristics of reflux episodes and symptom association in patients with erosive esophagitis and nonerosive reflux disease: study using combined impedance-pH off therapy.使用联合阻抗-pH 停治疗研究食管糜烂性食管炎和非糜烂性反流病患者的反流事件特征和症状相关性。
Am J Gastroenterol. 2010 May;105(5):1053-61. doi: 10.1038/ajg.2009.670. Epub 2009 Dec 8.
7
Pathophysiological characteristics of patients with non-erosive reflux disease differ from those of patients with functional heartburn.非糜烂性反流病患者的病理生理特征与功能性烧心患者不同。
Aliment Pharmacol Ther. 2004 Jul 1;20(1):81-8. doi: 10.1111/j.1365-2036.2004.01998.x.
8
Association of body mass index with heartburn, regurgitation and esophagitis: results of the Progression of Gastroesophageal Reflux Disease study.体重指数与烧心、反流及食管炎的关联:胃食管反流病进展研究结果
J Gastroenterol Hepatol. 2007 Nov;22(11):1728-31. doi: 10.1111/j.1440-1746.2006.04549.x.
9
Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.食管动力和食团转运异常随着胃食管反流病的严重程度而平行增加。
Aliment Pharmacol Ther. 2011 Aug;34(4):476-86. doi: 10.1111/j.1365-2036.2011.04742.x. Epub 2011 Jun 14.
10
Refractory GERD: increased body mass index is associated with persisting acid exposure but not hypersensitive esophagus or functional heartburn.难治性胃食管反流病:体重指数增加与持续的酸暴露有关,但与食管超敏反应或功能性烧心无关。
Eur J Gastroenterol Hepatol. 2013 Dec;25(12):1450-5. doi: 10.1097/MEG.0b013e328365d2a8.

引用本文的文献

1
Pathophysiology of Gastroesophageal Reflux Disease.胃食管反流病的病理生理学
Digestion. 2025 Jun 25:1-17. doi: 10.1159/000547023.
2
The Clinical Spectrum of Gastroesophageal Reflux Disease: Facts and Fictions.胃食管反流病的临床谱:事实与虚构
Visc Med. 2024 Oct;40(5):242-249. doi: 10.1159/000536583. Epub 2024 Mar 13.
3
Risk factors associated with functional esophageal disorders (FED) versus gastroesophageal reflux disease (GERD).与功能性食管疾病(FED)相关的风险因素与胃食管反流病(GERD)。
Surg Endosc. 2024 May;38(5):2842-2849. doi: 10.1007/s00464-024-10714-0. Epub 2024 Mar 25.
4
Gastro-esophageal diagnostic workup before bariatric surgery or endoscopic treatment for obesity: position statement of the International Society of Diseases of the Esophagus.肥胖的胃食管诊断检查:国际食管疾病学会的立场声明。
Dis Esophagus. 2024 Apr 27;37(5). doi: 10.1093/dote/doae006.
5
Effect of Body Weight and Obesity on Esophageal Function.体重和肥胖对食管功能的影响。
Physiol Res. 2023 Aug 31;72(4):525-537. doi: 10.33549/physiolres.935067.
6
The inappropriate use of proton pump inhibitors and its associated factors among community-dwelling older adults.社区居住的老年人中质子泵抑制剂的不当使用及其相关因素。
Heliyon. 2021 Jul 15;7(7):e07595. doi: 10.1016/j.heliyon.2021.e07595. eCollection 2021 Jul.
7
Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art.胃食管反流病的药物治疗管理:最新进展综述。
Drug Des Devel Ther. 2021 Apr 19;15:1609-1621. doi: 10.2147/DDDT.S306371. eCollection 2021.
8
Elimination of Dietary Triggers Is Successful in Treating Symptoms of Gastroesophageal Reflux Disease.消除饮食诱因可成功治疗胃食管反流病症状。
Dig Dis Sci. 2021 May;66(5):1565-1571. doi: 10.1007/s10620-020-06414-z. Epub 2020 Jun 24.
9
Efficacy and Safety of AlbisD Compared With Omeprazole 20 mg in Patients With Non-erosive Reflux Disease: A Randomized, Open-label, Active-controlled, Pilot Study.在非糜烂性反流病患者中,AlbisD与20毫克奥美拉唑相比的疗效和安全性:一项随机、开放标签、活性对照的试点研究。
J Neurogastroenterol Motil. 2019 Jul 1;25(3):403-412. doi: 10.5056/jnm18185.
10
Sleeve Gastrectomy, GERD, and Barrett's Esophagus: It Is Time for Objective Testing.袖状胃切除术、胃食管反流病和巴雷特食管:是时候进行客观检测了。
Obes Surg. 2019 Jul;29(7):2312-2313. doi: 10.1007/s11695-019-03902-8.